Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insight to Neglected Biomarkers in COVID-19: A Comprehensive Narrative Review".

Biomarker insights·2026

Same author

Dermatophytosis in Iran: a sharp increase in cases caused by <i>Trichophyton mentagrophytes</i> var. <i>indotineae</i>.

IMA fungus·2026

Same author

Inflammation at the crossroads of reproduction: SIRI as a prognostic signature of female infertility in hybrid regression-machine learning models.

Archives of gynecology and obstetrics·2026

Same author

Epidemiological and clinical profile of malaria patients in Isfahan Province, Iran: a retrospective analysis from 2009 to 2025.

Malaria journal·2025

Same author

Toxocara Infection and Its Association With Neurological and Psychiatric Disorders: A Systematic Review and Meta-Analysis.

Tropical medicine & international health : TM & IH·2025

Same author

Evaluating the predictive power of the body roundness index (BRI) versus traditional obesity measures for female infertility: a hybrid approach using regression models and machine learning algorithms on cross-sectional data.

Journal of health, population, and nutrition·2025

Search research articles

Related Experiment Video

Updated: Jan 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Comprehensive Management of HIV With Multiple Opportunistic Infections: A Case Report.

Mohammad Javad Boozhmehrani^1,2, Akbar Hoseinnejad^2,3, Sara Lesani⁴

¹Department of Medical Parasitology, School of Medicine Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.

Clinical Case Reports

|October 13, 2025

Summary

Managing human immunodeficiency virus (HIV) patients with multiple opportunistic infections needs teamwork and prompt antiretroviral therapy. Individualized care and monitoring are key for better survival in complex co-infection cases.

Keywords:

HIV candidiasis cryptosporidiosis opportunistic infections tuberculosis

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Related Experiment Videos

Last Updated: Jan 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Area of Science:

Infectious Diseases
Immunology
Pharmacology

Background:

Human immunodeficiency virus (HIV) infection can lead to opportunistic infections (OIs) due to immune suppression.
Managing HIV patients with multiple OIs presents significant clinical challenges.
Co-infections in HIV-positive individuals complicate treatment regimens and prognoses.

Purpose of the Study:

To outline effective management strategies for HIV patients with multiple opportunistic infections.
To emphasize the importance of a multidisciplinary approach in complex HIV co-infection scenarios.
To highlight the role of antiretroviral therapy (ART) and drug-drug interaction management.

Main Methods:

Review of clinical guidelines and best practices for managing HIV and OIs.
Analysis of factors influencing treatment outcomes in complex co-infection cases.
Emphasis on coordinated care and vigilant patient monitoring.

Main Results:

A multidisciplinary approach is crucial for effective management.
Timely initiation of antiretroviral therapy (ART) is essential.
Careful adjustment for drug-drug interactions is necessary to optimize treatment.
Coordinated care and monitoring significantly improve patient survival.

Conclusions:

Individualized treatment strategies are vital for complex HIV co-infection scenarios.
Effective management hinges on a comprehensive, coordinated, and vigilant approach.
Optimizing ART and managing interactions are key to improving outcomes for HIV patients with OIs.